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This article describes plug-based microﬂuidic technology that enables rapid detection and drug
susceptibility screening of bacteria in samples, including complex biological matrices, without pre-
incubation. Unlike conventional bacterial culture and detection methods, which rely on incubation
of a sample to increase the concentration of bacteria to detectable levels, this method conﬁnes indi-
vidual bacteria into droplets nanoliters in volume.When single cells are conﬁned into plugs of small
volume such that the loading is less than one bacterium per plug, the detection time is proportional
to plug volume. Conﬁnement increases cell density and allows released molecules to accumulate
around the cell, eliminating the pre-incubation step and reducing the time required to detect
the bacteria. We refer to this approach as ‘stochastic conﬁnement’. Using the microﬂuidic hybrid
method, this technology was used to determine the antibiogram – or chart of antibiotic sensitivity
– of methicillin-resistant Staphylococcus aureus (MRSA) to many antibiotics in a single experiment
and to measure the minimal inhibitory concentration (MIC) of the drug cefoxitin (CFX) against
this strain. In addition, this technology was used to distinguish between sensitive and resistant
strains of S. aureus in samples of human blood plasma. High-throughput microﬂuidic techniques
combined with single-cell measurements also enable multiple tests to be performed simultaneously
on a single sample containing bacteria. This technology may provide a method of rapid
and effective patient-speciﬁc treatment of bacterial infections and could be extended to a variety
of applications that require multiple functional tests of bacterial samples on reduced timescales.
Introduction
In this manuscript, we demonstrate a method of rapid bacterial
detection and drug susceptibility screening by using plug-
based microﬂuidics to expedite the diagnosis and treatment
of bacterial infections. Bacterial infections are a major health
problem, leading to more than 130 000 deaths annually just
from sepsis in the United States alone.1 These deaths are
often the result of nosocomial, or hospital-acquired, infections
and frequently involve drug-resistant strains of bacteria.2,3 In
addition, bacteremia, the presence of bacteria in the blood,
is one of the major causes of sepsis and generally requires a
minimumof a day ormore to diagnose, increasing the chances of
patient mortality.4 Patient mortality rates further increase when
inappropriate antimicrobial treatment is administered, which is
estimated to occur in 23–30% of cases.4
Shortening the time necessary to detect and identify an
effective antibiotic regimen to treat bacterial infections could
signiﬁcantly decrease the mortality rate and reduce the cost
of treating patients with sepsis and other aggressive bacterial
infections.5 However, attempts to reduce the assay time of tradi-
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tional diagnosis and characterization techniques are impeded by
the necessity to incubate bacterial specimens for hours to days
to increase the cell density in the sample to detectable levels.
To overcome this challenge, new PCR-based detection methods
enable diagnosis in the 1–4 hour time frame.6,7 However, these
methods only provide a genetic proﬁle of the infecting bacterial
species and lack the ability to directly test the bacteria’s function,
such as susceptibility to particular antibiotics. Although some
types of antibiotic resistance have genetic markers, the mecA
gene, for instance,8 genetic markers have not been identiﬁed for
all antibiotic-resistant strains of bacteria. Therefore, antibiotic
susceptibility is more accurately determined by a functional
assay, especially for bacterial strains with unknown resistance
mechanisms.
Microﬂuidics is an attractive platform for rapid single-cell
functional analysis.9–17 Plugs – droplets of aqueous solution
surrounded by a ﬂuorinated carrier ﬂuid – provide a simple
platform for manipulating samples with no dispersion or losses
to interfaces.18,19 Here, we show that microﬂuidic plug-based
assays provide the ability to reduce detection time by conﬁning
bacteria into nanoliter-sized plugs. This conﬁnement – we refer
to it as ‘stochastic conﬁnement’ – decreases the detection time
by conﬁning the sample into plugs that either have a single
bacterium or are empty. This approach increases the effective
concentration of the bacterium and allows released molecules
to accumulate in the plug. Such stochastic conﬁnement
is commonly used for single-cell analysis in microﬂuidic
devices,9,12,14,20–22 and similar techniques have been used for
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single-molecule and single-enzyme work.23–28 Microﬂuidics also
enables simultaneous execution of numerous assays of bacterial
function from a single bacterial sample in the same experiment,
which is especially useful for rapid antibiotic susceptibility
screening. Previously, gel microdroplets have been utilized for
susceptibility screening.29,30 However, this method did not take
advantage of the stochastic conﬁnement effects in plugs or high-
throughput screening methods of current microﬂuidic technolo-
gies. Here, we applied this technology to characterize the drug
sensitivity of a drug-resistant strain of Staphylococcus aureus (S.
aureus) andmeasure theminimal inhibitory concentration of the
antibiotic cefoxitin (CFX). We also successfully distinguished
between sensitive and resistant strains of S. aureus in infected
samples of human blood plasma. This technology offers
two advantages over traditional bacterial detection and drug
screening methods: (1) stochastic conﬁnement of single cells
from dilute samples concentrates the bacteria, eliminates the
need for pre-incubation, and reduces detection time; and (2) each
assay can be performed with an individual bacterium, enabling
hundreds of assays to be performedbyusing a single, low-density
bacterial sample without pre-incubation. This technology will
reduce the time needed to diagnose bacterial infections and
could eventually enable patient-speciﬁc antibiotic regimens.
Experimental
Bacterial cell culture
Cells were obtained from ATCC [S. aureus ATCC# 25923
(MSSA) andS. aureusATCC# 43300 (MRSA)]. Stock solutions
of the cells were made by using Luria–Bertani media Miller
formulation (LB) (BD, Sparks, MD) containing 30% (v/v)
glycerol and stored at −80 ◦C. For each experiment, a vial of
frozen stock was brought to room temperature, streaked onto
a Modiﬁed Trypticase Soy Agar (TSA II, BD, Sparks, MD)
plate, and incubated overnight at 30 ◦C.Colonies from the plates
were transferred to LB and cultured at 37 ◦C and 140 rpm for
3 h at which point OD600 was 1.5–2.0. Cell densities were then
adjusted by diluting in LB. To maintain sterility, all procedures
were performed in a biosafety cabinet and all tubing, devices,
syringes, and solutions used were either autoclaved, sterilized by
EtOH, packaged sterile, or ﬁltered through a 0.45 lm PES or
PTFE ﬁlter.
Comparing detection times of bacteria in nanoliter plugs and
milliliter-scale culture
Plugs were formed by using the general methods described
previously.31,32 Plugs were formed in a three-inlet PDMS device
with 100 lm wide channels by ﬂowing S. aureus culture in
LB at 2 × 105 CFU mL−1 at 1 lL min−1, a 20% alamarBlue
solution in saline at 1 lL min−1, and ﬂuorinated carrier ﬂuid
at 5 lL min−1. Twenty-ﬁve plugs were collected in the channel.
Inlets and the outlet were sealed with silicon grease, and the
device was placed in a Petri dish containing LB for incubation.
The same aqueous solutions were mixed 1 : 1 (total volume
0.6 mL) in a 14 mL polypropylene round-bottomed tube (BD
Falcon, Franklin Lakes, NJ). After 2.8 h, plugs were made from
the milliliter-scale culture by using the same method, ﬂowing
the cell culture containing alamarBlue into both aqueous inlets.
Both sets of plugs were immediately imaged by using an epi-
ﬂuorescence microscope (IRE2, Leica) with a Cy3 (Chroma
41007,Cy3) ﬁlter anda 10× 0.3NAobjective for a 5ms exposure
time with binning set to 4 and gain set to 200. Fluorescence
images of plugs were processed by subtracting the average
background intensity from all images. Linescans [Fig. 1(b)] with
a width of 25 pixels were taken along the long axis of each plug.
Experiment to compare plug volume to detection time
PDMS devices with channel widths ranging from 200 to 800 lm
were prepared. Teﬂon tubing with a diameter similar to that of
the channel was cut at a 45◦ angle, inserted into the device up
to the inlet junction, and sealed in place by using PDMS. For
Fig. 1(c) and 1(d), plugs were formed as described previously,
with the exception that the 1500 nL plugs were made via
aspiration by using a manual aspirator. In addition, 1 nL plugs
were formed in PTFE tubing with an outer diameter (OD) of
200 lm and an inner diameter (ID) of 90 lm, 690 nL plugs
were formed in PTFE tubing with an OD of 700 lm and an
ID of 600 lm, 100 and 120 nL plugs were formed in PTFE
tubing with an OD of 800 lm and an ID of 400 lm, 12.6 nL
plugs were formed in PTFE tubing with an OD of 260 lm
and an ID of 200 lm, and 1500 nL plugs were formed in
PTFE tubing with an OD of 1100 lm and an ID of 1000 lm.
Plugs were collected in the Teﬂon tubing, the tubing was sealed
with wax, and the tubing was placed in a Petri dish containing
LB for incubation and imaging. Incubation and imaging were
performed in a microscope incubator (Pecon GmbH, Erbach,
Germany). Time zero is deﬁned as the time at which the sample
entered the incubator, which was less than 20 min after sample
preparation. Fluorescence measurements were taken with 5 ms
exposure times with a 5 × 0.15 NA objective by using a 1×
camera coupler for 1, 12.6, 100, and 690 nL plugs, and a 0.63×
camera coupler was used for 1500 nL plugs. Plugs 140 nL in
volume were imaged with 10 ms exposure times with a 5 × 0.15
NA objective by using a 0.63× camera coupler.
Plugs were analyzed by ﬁrst separating them from the
background by thresholding to exclude intensity below 250.
The average intensity of the thresholded plugs was measured.
Over time, the intensity of the plugs diverged into two groups:
occupied plugs and unoccupied plugs. All occupied plugs had a
change in intensity more than two-fold greater than the change
in intensity of unoccupied plugs. Detection time is deﬁned as the
time at which the fold change in intensity of the occupied plugs
compared to the change in intensity of unoccupied plugs reaches
amaximum. The fold change in intensity is deﬁned as the change
in intensity of an occupied plug divided by the average change
in intensity of an unoccupied plug [eqn (1)].
Fold change(t = ti) = Occupied plug (I t = ti − I t = 1)/
Unoccupied plug (I t = ti − I t = 1) (1)
In eqn (1), I t = ti is intensity at time point i. The intensity of the
empty plugs is the average of all empty plugs in each experiment.
Screening susceptibility of bacteria to antibiotics
For antibiotic screening experiments (Fig. 2), an array of 50 nL
antibiotic plugs was aspirated into Teﬂon tubing (200 lm ID)
by using a manual aspirator. Air spacers were included between
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Fig. 1 Stochastic conﬁnement of bacteria into plugs reduces detection time. (a) Schematic drawing illustrates the increase in cell density resulting
from the stochastic conﬁnement of an individual bacterium in a nanoliter-sized plug. While most plugs are empty, a few are occupied by a single
bacterium at an effective concentration greater than the initial concentration. (b) Schematic drawing illustrates the experimental procedure to compare
the detection of bacteria incubated in nanoliter-sized plugs and bacteria incubated in a milliliter-scale culture. See text for details. Linescans indicate
that conﬁning the bacteria at the beginning of incubation (t = 0) led to a few occupied plugs with a high ﬂuorescence intensity and many empty plugs
with low ﬂuorescence intensity (solid line). All plugs made from the milliliter-scale culture had an intermediate ﬂuorescence intensity (dotted line).
(c) When conﬁning single bacteria into plugs, the detection time decreased with the log of the plug volume. (d) The detection times measured for
bacteria incubated in plugs () were similar to detection times measured for bacteria incubated in 96-well plates (×) with similar initial cell densities.
each antibiotic plug to prevent merging of adjacent antibiotic
plugs and to enable indexing of plugs in the output array. Plugs
of saline solution were included as the ﬁrst and last plugs
in the pre-formed array to serve as positive controls and are
referred to as blank conditions. The Teﬂon tubing containing
the array of antibiotic plugs was sealed into a device inlet by
using wax (Hampton Research, Aliso Viejo, CA). To screen
the susceptibility of MRSA (methicillin-resistant S. aureus)
and MSSA (methicillin-sensitive S. aureus) to each antibiotic,
bacterial samples and indicator were merged with the pre-
formed array of antibiotic conditions by using the microﬂuidic
hybrid method.31 Bacterial samples were at a density of 4 ×
105 CFUmL−1 in LB, and viability indicator solution was made
by mixing four parts of alamarBlue solution (AbD Serotec,
Oxford,UK)with six parts of 150mMNaCl. The ﬂow rate of the
antibiotic array was 0.25 lL min−1, the ﬂow rate of the bacterial
solution was 0.5 lL min−1, and the ﬂow rate of the viability
indicator was 0.25 lL min−1. The carrier ﬂuid was FC40 (Acros
Organics, Morris Plains, NJ) with a ﬂow rate of 1.6 lL min−1.
For each antibiotic plug in the pre-formed array, approximately
50 smaller plugs (4 nL in volume) were formed, each potentially
containing a single bacterium. The resulting plugs were collected
in a coil of Teﬂon tubing (150 lm ID).
After plug formation, the tubing was disconnected from the
PDMS device, and the ends were sealed with wax. The Petri
dish containing the tubing was ﬁlled with 20 mL of LB solution
to prevent evaporation of the plugs during incubation. The
plugs were immediately transferred to a microscope incubator
(Pecon GmbH, Erbach, Germany). Time zero is deﬁned as the
time when the plugs entered the incubator, which was about
20 min after plugs were formed. Fluorescence measurements for
the plugs were recorded by using an inverted epi-ﬂuorescence
microscope (DMI6000, Leica, Bannockburn, IL) with a 10 ×
0.3 NA objective (HCX PL Fluotar) coupled to a CCD camera
ORCAERG1394 (12-bit, 1344× 1024 resolution) (Hamamatsu
Photonics) by using a 0.63× camera coupler. Images were taken
of each plug by usingMetamorph Imaging Software (Molecular
Devices, Sunnyvale, CA) every 30 min with exposure times of
5 ms. Plugs were analyzed by ﬁrst separating them from the
background by thresholding to exclude intensity below 250.
The average intensity of the thresholded plugs was measured.
The change in intensity at time point ti is I t = ti − I t = 1. In the
experiments described inFig. 2(c), 3(b) and 3(c), the ﬂuorescence
intensity of the plugs was normalized by setting the intensity of
the brightest plug to 100.
Detection and drug susceptibility screening of MRSA and
MSSA in human blood plasma
ForFig. 4, cells were suspended in a 1 : 1mixture of humanblood
plasma (pooled normal plasma George King Bio-Medical,
Overland Park, KS) and LB containing 40% alamarBlue. Plugs
were formed and collected in Teﬂon tubing (200 lm ID).
Images were taken with a 5 × 0.15 NA objective with a 0.63×
camera coupler. Texas red pictures were taken every 10 min
with exposure times of 25 ms. A brightﬁeld image was taken
at the beginning and end of the experiment. Linescans of
original plug images were taken at time 0 and time 7.5 h.
Adobe Photoshop was used to enhance the contrast of the plugs
shown in Fig. 4. Fluorescence intensities were normalized to the
maximum concentration at t = 0 for Fig. 4(b)–(e).
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Fig. 2 A combination of stochastic conﬁnement with the microﬂuidic hybrid method was used to screen many antibiotics against the same bacterial
sample. (a) Schematic drawing illustrates the formation of plugs of bacteria, viability indicator, and antibiotic from a pre-formed array of plugs of
different antibiotics. Approximately 50 plugs were formed with each antibiotic in the screen. (b) The increase in ﬂuorescence intensity of the control
plugs with no antibiotic (+, Blank1, positive control) and vancomycin (, VCM, negative control) are shown. After incubation, four plugs contained
live bacteria in the positive control sample, but no plugs contained live bacteria in the negative control sample treated with vancomycin, indicating
that bacteria were not resistant to this antibiotic. (c) Bar graph shows the results of the antibiotic screen against the methicillin-resistant S. aureus
(MRSA), indicating that this strain ofMRSAwas resistant to four antibiotics, but sensitive to two. The bars show the average increase in ﬂuorescence
intensity of all plugs that were above (solid) or below (striped) three times the intensity of the VCM baseline (see Experimental for details). N, shown
above each bar, equals the number of plugs for each condition, and the error bars show the standard error. See ESI† for statistical analysis. (d) Chart
shows the agreement between the susceptibility proﬁles (S, sensitive and R, resistant) of MRSA determined by the plug-based microﬂuidic screen
and the control susceptibility screen using Mueller–Hinton plates. See text for details.
A detailed explanation of following procedures can be found
in the supplemental material: microﬂuidic device design and
fabrication, ﬂowing solutions into the microﬂuidic devices,
antibiotic preparation, antibiotic testing on plates, comparing
detection times of bacteria in nanoliter plugs and 96-well plates,
determining the minimal inhibitory concentration of a drug
against a bacterial sample, and statistical analysis of screening
results.
Results and discussion
Stochastic conﬁnement of individual bacteria into plugs
nanoliters in volume reduces detection time
To reduce the time required to detect bacteria in a sample, we
designed a microﬂuidic device to conﬁne a single bacterium into
plugs nanoliters in volume. In principle, when generating plugs
with a small volume from a solution with a low concentration of
bacteria, much of the volume of the initial solution forms plugs
that contain no bacteria. There are a few plugs occupied by a
single bacterium. As a result, the concentration of bacteria in
the occupied plugs is greater than the concentration of bacteria
in the initial solution. For example, if plugs nanoliters in volume
were made from a culture with an initial bacterial concentration
of 105 CFU mL−1, one in ten plugs would receive a single
bacterium, as illustrated in Fig. 1(a). The concentration of cells
in these occupied plugs would be one bacterium per nanoliter or
106 CFU mL−1. In other words, 105 CFU mL−1 corresponds on
average to 0.1 bacterium per 1 nL, and conﬁning this solution
into nanoliter plugs creates many plugs with no bacteria per
nanoliter and a few plugs with one bacterium per nanoliter.
CFUmL−1 refers to the colony forming units (CFU), a measure
of live bacteria, per milliliter.
To monitor the presence of metabolically active bacteria in
plugs, a ﬂuorescent viability indicator, alamarBlue, was added
to the cultures. The active ingredient of alamarBlue is the
ﬂuorescent redox indicator resazurin.33 Resazurin is reduced
by electron receptors used in cellular metabolic activity, such
as NADH and FADH, to produce the ﬂuorescent molecule
resofurin. Therefore, ﬂuorescence intensity in a plug is correlated
with the presence and metabolic activity of a cell, in this
case, a bacterium. Because resazurin indicates cell viability,
resazurin-based assays have been used previously in antibiotic
testing.34–37 Here, we use resazurin to detect both the presence
of a live bacterium and the response of bacteria to drugs,
such as antibiotics. We postulated that stochastic conﬁnement
would decrease the detection time, because the bacterium is at
an effectively higher concentration when conﬁned in a plug
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Fig. 3 Amicroﬂuidic plug-based assaywas used to identify theminimal
inhibitory concentration (MIC) of cefoxitin (CFX) for methicillin-
sensitive S. aureus (MSSA) andmethacillin-resistant S. aureus (MRSA).
(a) Schematic drawing illustrates the formation of plugs of bacteria,
viability indicator, and an antibiotic at varying concentrations. In the
schematic, numbers inside the pre-formed plugs symbolize the ﬁnal
concentration of CFX in those plugs. (b and c) Using 24 mg L−1
CFX as the baseline, graphs show the average change in ﬂuorescence
intensity of plugs greater than (solid) and less than (striped) three times
the baseline for MRSA (b) and MSSA (c). N, shown above each bar,
equals the number of plugs for each condition, and the error bars show
the standard error. These results indicated thatMRSAhas a higherMIC
than MSSA. See ESI† for statistical analysis.
than in the starting solution, and the signal-to-noise required
for detection would be reached sooner as the product of the
reduction of resazurin accumulates in the plug more rapidly.
To demonstrate the ability of stochastic conﬁnement to reduce
the detection time, a single sample of S. aureus containing the
ﬂuorescent viability indicator was split – half of the culture
was used to generate plugs nanoliters in volume, and the other
half remained as a milliliter-scale culture. Both the nanoliter
plugs and the milliliter-scale culture were incubated for 2.8 h
at 37 ◦C. After incubation, the milliliter-scale culture was also
used to form plugs. This experimental procedure is illustrated
in Fig. 1(b). Conﬁning bacteria into plugs nanoliters in volume
reduced the time required to detect a change in ﬂuorescence
intensity of the viability indicator. Bacteria conﬁned to and
Fig. 4 A combination of stochastic conﬁnement with the plug-based
microﬂuidic assay was used to determine susceptibility of bacteria to
an antibiotic in a natural matrix, blood plasma. (a) Schematic drawing
illustrates the formation of the plugs of bacteria, viability indicator,
antibiotic, and the plasma/LB mixture. (b–e) Linescans indicate that
ﬂuorescence increases after 7.5 h (blue solid line) in the cases of no
antibiotic or bacteria resistant to the antibiotic. (b and c) Images
and linescans of four representative plugs made from a 1 : 1 blood
plasma/LB sample inoculated with MRSA without (left) and with
(right) the addition of ampicillin (AMP). (d and e) Images and linescans
of four representative plugs made from a 1 : 1 blood plasma/LB sample
inoculated with MSSA without (left) and with (right) the addition of
AMP. Linescans show a change in ﬂuorescence intensity across width of
the images for plugs at t = 0 (red dashed line) and t = 7.5 h (solid blue
line). The scale bar in (b) applies to all images. All images were contrast-
enhanced for clarity and should be interpreted qualitatively; linescans
of raw intensities are provided to convey the information quantitatively.
incubated in nanoliter-sized plugs showed a greater change in
ﬂuorescence intensity after 2.8 h than the bacteria incubated in
the ‘unconﬁned’ milliliter-scale culture. Linescans of the plugs
of bacteria that were incubated in plugs showed many empty
plugs with low ﬂuorescence intensity and a few occupied plugs
with high ﬂuorescence intensity [Fig. 1(b), top row of plugs and
solid line]. However, linescans of plugs of bacteria that were
incubated in the milliliter-scale culture have a lower, uniform
ﬂuorescence intensity [Fig. 1(b), bottom row of plugs and dotted
line]. Therefore, bacteria conﬁned to nanoliter-sized plugs could
be detected earlier than bacteria in a milliliter-scale culture.
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In plugs containing a single bacterium, the detection time was
proportional to plug volume. The detection time was deﬁned as
the time at which the increase in ﬂuorescence intensity reached a
maximum. When single bacteria were conﬁned in plugs ranging
from 1 to 1500 nL in volume, the detection time increased with
the log of plug volume [Fig. 1(c)], implying that bacteria were
dividing exponentially inside the plugs. This result is similar to
previous estimates that the detection time decreases by about
1.5 h for every order of magnitude increase in cell density.38 The
detection times measured for bacteria incubated in plugs were
similar to detection times measured for bacteria incubated in
a 96-well plate from cultures with similar initial cell densities
[Fig. 1(d)]. This result implies that incubation in plugs had no
adverse effects on the growth of bacteria and suggests that the
reduction in detection time is the result of higher initial cell
density due to conﬁnement.
The sensitivity of a bacterial strain to many antibiotics can be
screened in a single experiment by using plug-based microﬂuidics
Next, we extended this system to screen a single bacterial sample
against many antibiotics to generate an antibiogram, or chart of
drug susceptibility. A pre-formed array of plugs of six antibio-
tics – two beta-lactams (ampicillin, AMP, and oxicillin, OXA); a
cephalosporin (cefoxitin, CFX); a ﬂuoroquinolone (levoﬂoxicin,
LVF); vancomycin, VCM; and a macrolide (erythromycin,
ERT) – was generated by aspiration. Antibiotics were tested
at the breakpoint concentration,39 the accepted concentration
of antibiotic at which bacterial susceptibility is determined
[Fig. 2(d)]. Using the microﬂuidic hybrid method,31 the plugs
in the antibiotic array were merged with methicillin-resistant
S. aureus (MRSA, ATCC# 43300) at an initial cell density of
4 × 105 CFU mL−1 and the viability indicator on-chip to form
plugs approximately 4 nL in volume, as illustrated in Fig. 2(a).
Since stochastic conﬁnement of the bacterium into nanoliter-
sized plugs generates many empty plugs, approximately 50
plugs were generated for each antibiotic condition such that
it was statistically likely that each condition would contain
several plugs occupied by a single bacterium. In total, 400–
500 plugs were formed for each screen, which consisted of six
drug conditions and two blank conditions. All 400–500 plugs
were collected in the same coil of tubing. A blank condition
was located at the beginning and end of the array to ensure
that the position in the array did not affect the assay results. The
merged plugs were collected and incubated for 7 h at 37 ◦C.After
incubation, the ﬂuorescence intensity of the plugswasmeasured.
Occupied plugs containing an antibiotic towhich the bacterial
strain was resistant showed increased ﬂuorescence intensity,
whereas plugs containing an antibiotic to which the bacterial
strain was sensitive showed no signiﬁcant increase in ﬂuores-
cence intensity [Fig. 2(c)]. Plugs containing VCMwere used as a
negative control, because VCM inhibited this S. aureus strain in
macro-scale experiments, in agreement with expectations40 (data
not shown). The average increase in ﬂuorescence from all plugs
containing VCMwas used as a baseline to which the increase in
ﬂuorescence intensity of all other plugs was compared [Fig. 2(b):
, VCM]. Five out of 58 control plugs (9%) with no antibiotic
[Fig. 2(b): +, Blank1, only the ﬁrst 50 plugs shown] showed an
increase in ﬂuorescence intensity more than three times greater
than the VCM baseline, indicating that they were occupied by
bacteria. However, the other plugs with no antibiotic showed
an increase in ﬂuorescence intensity similar to the baseline,
indicating that they were unoccupied [Fig. 2(b): +, Blank1].
By comparing the ﬂuorescence increase in each plug with the
VCM baseline, we can determine which antibiotics were toxic
to the bacteria. Plugs occupied with a viable bacterium showed
an increase in ﬂuorescence intensity greater than three times
the VCM baseline. Fig. 2(c) shows the average intensities of
plugs that showed an increase in ﬂuorescence intensity greater
than three times the baseline (black bars) and plugs that showed
an increase in ﬂuorescence intensity less than three times the
baseline (striped bars). No plugs containing VCM or LVF had a
ﬂuorescence increase greater than three times the baseline, indi-
cating thatMRSAwas sensitive to these antibiotics (see ESI† for
statistical analysis). Poisson statistics [eqn (2)] can be used to pre-
dict the probability of not loading a bacterium into any of plugs
in the conditions LVF or VCM. In other words, eqn (2) predicts
the possibility of the LVF or VCM results being false-negative.
(2)
In eqn (2), f is the probability of having k bacteria in a plug
given an average bacterial loading of k bacteria per plug. The
experimentally determined k was 0.11, as 11% of control plugs
with no antibiotics received bacteria [Fig. 2(c): Blank1 and
Blank2]. For k = 0 and k = 0.11, we calculated the probability
of having an unoccupied plug to be 0.896. The probability
of having 49 unoccupied plugs is 0.89649, or 0.0046. Given
that LVF and VCM had at least 49 plugs, the probability of a
false-negative due to loading is less than 0.5%.
The results from the MRSA antibiotic screen were used to
make the antibiogram in Fig. 2(d). The antibiotics were tested
at the breakpoint concentration, and the ﬂuorescence data were
used to determine whether the bacterial strain was sensitive
(S) or resistant (R) to the antibiotic. Sensitive means that
no plugs containing a speciﬁc antibiotic showed an increase
in ﬂuorescence intensity greater than three times the VCM
baseline. Resistant means that at least one plug containing
a speciﬁc antibiotic showed increased ﬂuorescence intensity
greater than three times the VCM baseline. The susceptibility
proﬁle generated for MRSA by using the microﬂuidic screen
[Fig. 2(d)] was identical to the proﬁle generated by using
Mueller–Hinton agar plate tests and similar to previous reports
in the literature for MRSA.40 However, antibiotic sensitivity
testing is inﬂuenced by many factors, including bacterial load,
culturing conditions, temperature, bacterial strain, and type of
assay used to detect sensitivity. In addition, a cell population
might contain sub-populations of cells with variable sensitivity
to a given antibiotic. All of these factors should be considered
and further characterized before formulating guidelines for
implementing plug-based antibiotic sensitivity assays.
Plug-based methods can also be used to determine the minimal
inhibitory concentration (MIC) of an antibiotic against a
bacterial sample
Next, this microﬂuidic approach was used to determine theMIC
of the antibiotic cefoxitin (CFX) forMRSA andMSSA (Fig. 3).
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This assaywas similar to the antibiotic screening assay described
above, except that the pre-formed array of antibiotic plugs all
contained the same antibiotic and the concentration of that
antibiotic in each plug of the pre-formed array was different.
Again, plugs containing saline solution (blank condition) were
included at the beginning and end of the array to serve as
negative controls and to ensure that the ﬁrst and last plugs of
the array gave similar assay results. The positive control plugs
consisted of CFX at a concentration of 24 mg L−1, as both
strains were shown to be inhibited by CFX at this concentration.
Using the microﬂuidic hybrid method,31 plugs of the antibiotic
array were merged with bacteria and the ﬂuorescent viability
indicator as illustrated in Fig. 3(a) and incubated at 32 ◦C. Plugs
with MRSA were incubated for 6.75 h and plugs with MSSA
were incubated for 6.5 h. It should be noted that temperature
can affect the results of antibiotic sensitivity assays. Here, the
difference inMIC ofMRSA andMSSAwas discerned by assays
conducted at 32 ◦C.
After incubation, the ﬂuorescence intensity of the plugs was
measured. Here, the average increase in ﬂuorescence intensity
of plugs containing 24 mg L−1 CFX was used as the baseline
to which the increase in ﬂuorescence intensity of other plugs
was compared. BecauseMRSA is resistant to many beta-lactam
antibiotics, CFX should be less effective against the strain
MRSA. As expected, the MIC of CFX was higher for MRSA
(<8mgmL−1) than theMIC of CFX forMSSA (<4.0 mgmL−1)
[Fig. 3(b) and 3(c)]. These results validate the use of this plug-
based technology for screening both the susceptibility and the
minimal inhibitory concentration of many antibiotics against a
single bacterial sample.
Microﬂuidic bacterial detection and drug screening are
applicable to complex, natural matrices, including human
blood plasma
To validate the applicability of this method to detecting bacteria
in natural matrices, this method was used to detect bacteria in
a sample of human blood plasma. Bacterial strains MSSA or
MRSA were inoculated into pooled human blood plasma at a
concentration of 3 × 105 CFU mL−1. To test the sensitivity of
the bacteria to beta-lactams, the antibiotic ampicillin (AMP)
was added to the culture at the breakpoint concentration. The
inoculated plasma was then combined on-chip with viability
indicator as illustrated in Fig. 4(a). After 7.5 h of incubation at
37 ◦C, plasma samples infectedwithMRSAwere distinguishable
from samples infected with MSSA. While plugs containing
MRSA and AMP showed a similar increase in ﬂuorescence
intensity to plugs containingMRSA and noAMP [Fig. 4(b) and
4(c)], plugs containing MSSA and AMP showed no increase in
ﬂuorescence intensity [Fig. 4(d) and 4(e)].
Conclusions
Stochastic conﬁnement combined with plug-based microﬂuidic
handling methods accelerates bacterial detection and enables
rapid functional antibiotic screening. By using this method,
assays can be performed on a single bacterium, potentially
eliminating the need for pre-incubation. By conﬁning and
analyzing single bacterium in plugs, the detection time is now
determined by plug volume. We were able to achieve detailed
functional characterization of a bacterial sample in less than
7 h. We also demonstrated that a bacterium in a 1 nL plug
can be detected in as little as 2 h. The detection time is limited
by the formation and measurement of plugs of small volume
and is less dependent on the initial concentration and growth
rate of bacteria in the sample. This feature could be potentially
important for accelerated detection of slowly-growing species
such as Mycobacterium tuberculosis, a pathogen of signiﬁcant
importance world-wide.41 Here, we have demonstrated a screen
with 400–500 nL plugs. High-throughput screens with more
conditions and increased concentration of the sample would
require methods that can handle larger numbers of smaller
plugs, includingmethods for automated sorting and analysis.42–45
Upon incorporating such methods for handling and sorting
large numbers of plugs of small volume, this technique could
be used for the detection of bacteria in a sample at a cell density
much lower than 105 CFU mL−1. Since we are measuring the
activity of single cells, it is conceivable that detecting the presence
of even a single bacterium in a sample could be feasible.
Given that a typical 5 mL blood sample from a patient
with bacteremia contains a cell density of 100 CFU mL−1,46
this method is capable of performing dozens of functional
tests on such a sample. Patient-speciﬁc characterization of
bacterial species would not only lead to more rapid and effective
treatment, but such an advance would also enable in-depth
characterization of bacterial infections at the population level.
Such detailed characterization may aid in tracking and identi-
fying new resistance patterns in bacterial pathogens.47,48 While
clinical implementation of this technique would require further
testing to determine appropriate guidelines for the execution
and interpretation of plug-based sensitivity assays, this paper
highlights the advantages of the conﬁnement of single cells for
biological assays. The principles of these methods, stochastic
single-cell conﬁnement and multiple functional assays without
sample pre-incubation could also be applied to other areas,
including performing functional tests on ﬁeld samples, detecting
contamination of food or water, separating and testing samples
with mixtures of species, measuring functional heterogeneity in
bacterial populations, and monitoring industrial bioprocesses.
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